Furthermore, due to the progressive nature of T2D, many patients eventually require and benefit from insulin therapy, and thus sound evidence on the long-term effects of basal insulin is needed for optimizing clinical diabetes care. The gene discussed is INS; the disease is type 2 diabetes mellitus.